...have to disagree.....from the announcement...
ADMEDUS EXPANDS CARDIOCEL® MARKET AND ANTICIPATES RECORD SALES QUARTER
1. CardioCel® enters Hong Kong market and achieves initial sales in Italy and France
2. Regenerative tissue product on track for strongest sales quarter
...."I agree, to provide a forward statement saying it will be a 'record' quarter only to receive an average numbers is disappointing.".......is $1M in CardioCel sales not a record or enough?..
...have the company not more than doubled the target they set themselves for centre pick up?....
Quarterly, page-140
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $344.2M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 681 | $17.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.25 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |